Testing effectiveness (Phase 2)Study completedNCT00600275
What this trial is testing
A Phase I/II Study of BGT226 in Adult Patients With Advanced Solid Malignancies Including Patients With Advanced Breast Cancer
Who this might be right for
Solid TumorsBreast CancerCowden Syndrome
Novartis Pharmaceuticals 57